SensUs is the annual international student competition on Sensors for Health. Multidisciplinary teams of students in 14 universities in Europe, North-America, Asia, and Africa are developing biosensors for the detection of a selected biomarker. The competition culminates in the contest where the teams demonstrate their biosensors and their business models to the jury, companies, medical professionals, patients, and to the general public.
This year's competition challenges student teams to develop innovative biosensing systems for the measurement of adalimumab, a biological drug that is prescribed to patients suffering from rheumatoid arthritis (RA). RA affects around 1% of the world population. Disease onset is most frequent during middle age and women are affected 2.5 times as frequently as men. Measurement of adalimumab concentrations will enable more efficient and effective management of the disease.
TTP will be at SensUs 2019 at Eindhoven University of Technology to support the ongoing competition as well as support Team Joint Venture - Imperial College SensUs 2019, on their Biosensors project.